Pfizer Inc.
ANTI-CXCR5 ANTIBODIES AND COMPOSITIONS AND USES THEREOF
Last updated:
Abstract:
The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to CXCR5. The antibodies can be afucosylated and exhibit increased ADCC compared with the otherwise identical fucosylated antibodies. The invention includes uses, and associated methods of using the antibodies.
Status:
Application
Type:
Utility
Filling date:
20 Nov 2020
Issue date:
8 Apr 2021